4//SEC Filing
Booth Robert F. 4
Accession 0001599298-25-000022
CIK 0001599298other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:57 PM ET
Size
438.9 KB
Accession
0001599298-25-000022
Insider Transaction Report
Form 4
Booth Robert F.
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 totalExercise: $18.35Exp: 2035-01-02→ Common Stock (35,000 underlying) - Award
Stock Option (right to buy)
2025-01-02$9.18/sh+6,855$62,929→ 6,855 totalExercise: $18.35Exp: 2035-01-02→ Common Stock (6,855 underlying)
Footnotes (4)
- [F1]The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
- [F3]The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
- [F4]The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $62,900.
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001507567
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:57 PM ET
- Size
- 438.9 KB